Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Maki · SciRah

Researcher profile · Semantic Scholar

R. Maki

Share profile

R. Maki — researcher profile on SciRah

h-index: 95
Works: 424
Citations: 40K

Most-cited papers

A framework for advancing our understanding of cancer-associated fibroblasts
E. Sahai, I. Astsaturov, E. Cukierman, D. DeNardo +25 more
2020Nature Reviews. Cancer3,365 citations Open access
Semantic Scholar
Pembrolizumab in Advanced Soft Tissue and Bone Sarcomas: Results of SARC028, A Multicentre, Single arm, Phase 2 Trial
H. Tawbi, M. Burgess, V. Bolejack, B. A. Van Tine +20 more
2017The Lancet Oncology1,181 citations Open access
Semantic Scholar
The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients.
B. Alman, S. Attia, C. Baumgarten, C. Benson +53 more
2020European Journal of Cancer463 citations Open access
Semantic Scholar
Sorafenib for Advanced and Refractory Desmoid Tumors
M. Gounder, M. Mahoney, B. Van Tine, V. Ravi +21 more
2018New England Journal of Medicine387 citations Open access
Semantic Scholar
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
Lara E. Davis, V. Bolejack, C. Ryan, K. Ganjoo +13 more
2019Journal of Clinical Oncology220 citations
Semantic Scholar
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
M. Gounder, N. Agaram, S. Trabucco, V. Robinson +39 more
2022Nature Communications185 citations Open access
Semantic Scholar
Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial
C. Raut, N. Espat, R. Maki, D. Araujo +4 more
2018JAMA Oncology159 citations Open access
Semantic Scholar
Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas
Amanda R. Dancsok, D. Gao, Anna F. Lee, S. Steigen +5 more
2020Oncoimmunology154 citations Open access
Semantic Scholar
Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine.
G. Demetri, P. Schöffski, G. Grignani, J. Blay +7 more
2017Journal of Clinical Oncology148 citations
Semantic Scholar
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
G. Demetri, C. Antonescu, B. Bjerkehagen, J. Bovée +44 more
2020Annals of Oncology137 citations Open access
Semantic Scholar
Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review
L. Paoluzzi, R. Maki
2019JAMA Oncology131 citations
Semantic Scholar
Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
M. Markham, K. Wachter, N. Agarwal, M. Bertagnolli +22 more
2020Journal of Clinical Oncology123 citations Open access
Semantic Scholar
Clinical activity of pembrolizumab (P) in undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated/pleomorphic liposarcoma (LPS): Final results of SARC028 expansion cohorts.
M. Burgess, V. Bolejack, S. Schuetze, B. Van Tine +16 more
2019Journal of Clinical Oncology118 citations
Semantic Scholar
Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
J. Heymach, L. Krilov, A. Alberg, N. Baxter +18 more
2018Journal of Clinical Oncology113 citations
Semantic Scholar
Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG)†
J. Åhlén, N. Ahuja, M. Albertsmeier, W. Al-Refaie +102 more
2018Annals of Oncology91 citations Open access
Semantic Scholar
Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas
Amanda R. Dancsok, Nokitaka Setsu, D. Gao, J. Blay +4 more
2019Modern Pathology86 citations Open access
Semantic Scholar
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.
S. Stacchiotti, O. Mir, A. Le Cesne, B. Vincenzi +19 more
2018The Oncologist81 citations Open access
Semantic Scholar
Carcinosarcomas and Related Cancers: Tumors Caught in the Act of Epithelial-Mesenchymal Transition.
A. Pang, M. Carbini, A. Moreira, R. Maki
2018Journal of Clinical Oncology78 citations
Semantic Scholar
Overall survival and histology‐specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma
Shreyaskumar R. Patel, M. von Mehren, D. Reed, P. Kaiser +16 more
2019Cancer66 citations Open access
Semantic Scholar
Efficacy and Safety of Trabectedin or Dacarbazine in Patients with Advanced Uterine Leiomyosarcoma after Failure of Anthracycline-based Chemotherapy: Subgroup Analysis of a Phase 3, Randomized Clinical Trial
M. Hensley, Shreyaskumar R. Patel, M. von Mehren, K. Ganjoo +11 more
2017Gynecologic Oncology59 citations Open access
Semantic Scholar
TERT promoter mutations in solitary fibrous tumour
Elizabeth G. Demicco, K. Wani, D. Ingram, M. Wagner +5 more
2018Histopathology52 citations
Semantic Scholar
An IRAK1-PIN1 Signalling Axis Drives Intrinsic Tumour Resistance to Radiation Therapy
Peter H. Liu, Richa B. Shah, Yuanyuan Li, Arshi Arora +19 more
2019Nature Cell Biology50 citations Open access
Semantic Scholar
Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment.
Jalal A Khan, R. Maki, V. Ravi
2018Journal of Clinical Oncology49 citations
Semantic Scholar
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1
S. Chawla, B. Van Tine, S. Pollack, K. Ganjoo +17 more
2021Journal of Clinical Oncology46 citations
Semantic Scholar
Systemic treatments in MDM2 positive intimal sarcoma: a multicentre experience with anthracycline, gemcitabine and pazopanib within the World Sarcoma Network (WSN)
A. Frezza, T. Assi, Salvatore Lo Vullo, E. Ben-Ami +35 more
2019Cancer46 citations Open access
Semantic Scholar
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results
S. Attia, V. Bolejack, K. Ganjoo, S. George +12 more
2022Cancer Medicine45 citations Open access
Semantic Scholar
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma
Robin L. Jones, V. Ravi, A. Brohl, S. Chawla +12 more
2022JAMA Oncology43 citations Open access
Semantic Scholar
Brightline-1: phase II/III trial of the MDM2-p53 antagonist BI 907828 versus doxorubicin in patients with advanced DDLPS.
P. Schöffski, M. Lahmar, A. Lucarelli, R. Maki
2023Future Oncology42 citations Open access
Semantic Scholar
Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study
J. Blay, P. Schöffski, S. Bauer, A. Krarup-Hansen +4 more
2019British Journal of Cancer35 citations Open access
Semantic Scholar
Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma
Robin L. Jones, G. Demetri, S. Schuetze, M. Milhem +11 more
2018Annals of Oncology35 citations Open access
Semantic Scholar
First-in-human study of REGN3767 (R3767), a human LAG-3 monoclonal antibody (mAb), ± cemiplimab in patients (pts) with advanced malignancies.
K. Papadopoulos, N. Lakhani, M. Johnson, Haeseong Park +15 more
2019Journal of Clinical Oncology32 citations
Semantic Scholar
A phase II trial of regorafenib (REGO) in patients (pts) with advanced Ewing sarcoma and related tumors (EWS) of soft tissue and bone: SARC024 trial results.
S. Attia, V. Bolejack, K. Ganjoo, S. George +12 more
201732 citations
Semantic Scholar
SELNET Clinical practice guidelines for bone sarcoma.
J. Blay, E. Palmerini, J. Bollard, S. Aguiar +61 more
2022Critical reviews in oncology/hematology31 citations Open access
Semantic Scholar
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments.
S. Stacchiotti, Anna Maria Frezza, G. Demetri, J. Blay +57 more
2022Cancer Treatment Reviews28 citations Open access
Semantic Scholar
A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study
R. Riedel, K. Ballman, Yao Lu, S. Attia +16 more
2018The Oncologist27 citations Open access
Semantic Scholar
A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb‐004) in metastatic soft‐tissue sarcomas
Robin L. Jones, S. Chawla, S. Attia, P. Schöffski +13 more
2019Cancer26 citations Open access
Semantic Scholar
Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
M. Nathenson, Jun-Xiao Hu, R. Ratan, N. Somaiah +23 more
2022Clinical Cancer Research25 citations Open access
Semantic Scholar
Treatment of soft tissue sarcoma: a focus on earlier stages.
A. Gronchi, R. Maki, Robin L. Jones
2017Future Oncology25 citations
Semantic Scholar
Novel HMGA2-YAP1 fusion gene in aggressive angiomyxoma
Mee-Young Lee, Brandon DaSilva, Daniel C. Ramirez, R. Maki
2019BMJ Case Reports20 citations Open access
Semantic Scholar
A randomized phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2, and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
E. Rosenbaum, R. Chugh, C. Ryan, M. Agulnik +22 more
2022European Journal of Cancer19 citations Open access
Semantic Scholar
Follicular dendritic cell sarcoma and its response to immune checkpoint inhibitors nivolumab and ipilimumab
Mee-Young Lee, Carolina Bernabe-Ramirez, Daniel C. Ramirez, R. Maki
2020BMJ Case Reports19 citations Open access
Semantic Scholar
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
N. Berlow, R. Rikhi, Mathew Geltzeiler, Jinu Abraham +25 more
2018BMC Cancer19 citations Open access
Semantic Scholar
Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II Trials.
S. Akshintala, Nicole C. Mallory, Yao Lu, K. Ballman +6 more
2023The Oncologist18 citations Open access
Semantic Scholar
A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.
D. D'Adamo, M. Dickson, M. Keohan, R. Carvajal +10 more
2018The Oncologist18 citations Open access
Semantic Scholar
Randomized phase II trial of cabozantinib combined with PD-1 and CTLA-4 inhibition versus cabozantinib in metastatic soft tissue sarcoma.
B. Van Tine, V. Eulo, Jacqui Toeniskoetter, Tyler Ruff +13 more
2023Journal of Clinical Oncology17 citations Open access
Semantic Scholar
Increased tumor infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcoma
J. Lenz, C. Assenmacher, Victoria R Costa, Katie L Louka +7 more
2021Cancer Immunology and Immunotherapy17 citations Open access
Semantic Scholar
A Method to Summarize Toxicity in Cancer Randomized Clinical Trials
M. Carbini, M. Suárez-Fariñas, R. Maki
2018Clinical Cancer Research17 citations Open access
Semantic Scholar
Regorafenib for the Treatment of Sarcoma
J. Blay, F. Duffaud, S. George, R. Maki +1 more
2022Current Treatment Options in Oncology16 citations
Semantic Scholar
Results of the TAPPAS trial: An adaptive enrichment phase III trial of TRC105 and pazopanib (P) versus pazopanib alone in patients with advanced angiosarcoma (AS)
Robin L. Jones, V. Ravi, A. Brohl, S. Chawla +9 more
2019Annals of Oncology16 citations Open access
Semantic Scholar
Impact of Intraoperative Molecular Imaging after Fluorescent-Guided Pulmonary Metastasectomy for Sarcoma
F. Azari, G. Kennedy, Kevin Zhang, E. Bernstein +6 more
2022Journal of the American College of Surgeons15 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Attia×13
Invite
S. Attia — researcher profile on SciRah
Robin L. Jones×13
Invite
Robin L. Jones — researcher profile on SciRah
J. Blay×11
Invite
J. Blay — researcher profile on SciRah
Shreyaskumar R. Patel×9
Invite
Shreyaskumar R. Patel — researcher profile on SciRah

×9

Invite

K. Ganjoo — researcher profile on SciRah

Invite

S. Chawla — researcher profile on SciRah

Invite

R. Riedel — researcher profile on SciRah

Invite

B. Van Tine — researcher profile on SciRah

Lara E. Davis×7

Invite

Lara E. Davis — researcher profile on SciRah

Invite

S. Okuno — researcher profile on SciRah

Invite

D. Reinke — researcher profile on SciRah

Invite

V. Ravi — researcher profile on SciRah